ReviewAnnals of medicine and surgery (2012)2022
Recurrence of COVID-19 infection symptoms in short time; reinfection or reactivation? Three cases of three healthcare workers and a literature review.
Review in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since the beginning of the COVID-19 pandemic, many research papers have been published focusing on some recurrence cases of symptoms after a long period of free symptoms with a negative RT-PCR retest. There is no crucial evidence until now of the possibility of recurrence, immune system reactivation, or reinfection. Methods: Three cases of resident doctors who recovered from COVID-19 but represented symptoms with new positive RT-PCR were discussed. Clinical data, laboratory tests, RT-PCR results, and antibodies titers all were collected. Moreover, many cases from the literature have been reviewed and compared. Results: The long-term exposure has not succeeded in forming an effective immune response, especially, since they do not have any significant history of chronic illnesses or a diagnosed immune disorder. While the antibody response occurred only in the second patient, it did not prevent new infection, but did it control the severity of the infection or its complications? Conclusion: Our three patients are health workers and have been in direct contact with COVID-19 patients. The inflammatory response parameters may not be reliable in predicting the activation of the immune response and the formation of the antibodies. We still need to find answers for reactivation and reinfection issues.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.